|
1
|
Cook LB, Melamed A, Niederer H, Valganon
M, Laydon D, Foroni L, Taylor GP, Matsuoka M and Bangham CR: The
role of HTLV-1 clonality, proviral structure and genomic
integration site in adult T cell leukemia/lymphoma. Blood.
123:3925–3931. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Araujo TH, Barreto FK, Luiz Carlos A
Júnior and Miranda AC: Inferences about the global scenario of
human T-cell lymphotropic virus type 1 infection using data mining
of viral sequences. Mem Inst Oswaldo Cruz. 0:21–24. 2014.PubMed/NCBI
|
|
3
|
Bazarbachi A, Abou Merhi R, Gessain A,
Talhouk R, El-Khoury H, Nasr R, Gout O, Sulahian R, Homaidan F, de
Thé H, Hermine O and El-Sabban ME: Human T-cell lymphotropic virus
type I-infected cells extravasate through the endothelial barrier
by a local angiogenesis-like mechanism. Cancer Res. 64:2039–2046.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roomi MW, Kalinovsky T, Roomi NM, Cha J,
Rath M and Niedzwiecki A: In vitro and in vivo
effects of a nutrient mixture on breast cancer progression. Int J
Oncol. 44:1933–1944. 2014.
|
|
6
|
Roomi MW, Kalinovsky T, Roomi NW,
Niedzwiecki A and Rath M: Suppression of metastasis of
intratesticular inoculation of B16FO melanoma cells by a novel
nutrient mixture in male athymic nude mice. Exp Ther Med.
4:775–780. 2012.PubMed/NCBI
|
|
7
|
Niedzwiecki A, Roomi MW, Kalinovsky T and
Rath M: Micronutrient synergy - a new tool in effective control of
metastasis and other key mechanisms of cancer. Cancer Metastasis
Rev. 29:529–542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roomi MW, Kalinovsky T, Niedzwiecki A and
Rath M: Modulation of uPA, MMPs and their inhibitors by a novel
nutrient mixture in human glioblastoma cell lines. Int J Oncol.
45:887–894. 2014.PubMed/NCBI
|
|
9
|
Roomi MW, Kalinovsky T, Rath M and
Niedzwiecki A: Effect of a nutrient mixture on matrix
metalloproteinase-9 dimers in various human cancer cell lines. Int
J Oncol. 44:986–992. 2014.PubMed/NCBI
|
|
10
|
Roomi MW, Kalinovsky T, Niedzwiecki A and
Rath M: Modulation of u-PA, MMPs and their inhibitors by a novel
nutrient mixture in pediatric human sarcoma cell lines. Int J
Oncol. 43:1027–1035. 2013.
|
|
11
|
Roomi MW, Kalinovsky T, Niedzwiecki A and
Rath M: Modulation of u-PA, MMPs and their inhibitors by a novel
nutrient mixture in adult human sarcoma cell lines. Int J Oncol.
43:39–49. 2013.
|
|
12
|
Roomi MW, Kalinovsky T, Niedzwiecki A and
Rath M: Modulation of u-PA, MMPs and their inhibitors by a novel
nutrient mixture in human lung cancer and mesothelioma cell lines.
Int J Oncol. 42:1883–1889. 2013.
|
|
13
|
Roomi MW, Monterrey JC, Kalinovsky T, Rath
M and Niedzwiecki A: Inhibition of invasion and MMPs by a nutrient
mixture in human cancer cell lines: a correlation study. Exp Oncol.
32:243–248. 2010.PubMed/NCBI
|
|
14
|
Harakeh S, Abdel-Massih RM, Gil PR,
Sperling RA, Meinhardt A, Niedwiecki A, Rath M, Parak WJ and
Baydoun E: The effect of PEG-coated gold nanoparticles on the
anti-proliferative potential of Specific Nutrient Synergy.
Nanotoxicology. 4:177–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harakeh S, Diab-Assaf M, Niedzwiecki A,
Khalife J, Abu-El-Ardat K and Rath M: Apoptosis induction by Epican
Forte in HTLV-1 positive and negative malignant T-cells. Leuk Res.
30:869–881. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cha J, Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Ascorbate supplementation inhibits growth
and metastasis of B16FO melanoma and 4T1 breast cancer cells in
vitamin C-deficient mice. Int J Oncol. 42:55–64. 2013.PubMed/NCBI
|
|
17
|
Harakeh S, Diab-Assaf M, Khalife JC,
Abu-El-Ardat KA, Baydoun E, Niedzwiecki A, El-Sabban ME and Rath M:
Ascorbic acid induces apoptosis in adult T-cell leukemia.
Anticancer Res. 27:289–298. 2007.PubMed/NCBI
|
|
18
|
Cameron E, Pauling L and Leibovitz B:
Ascorbic acid and cancer: a review. Cancer Res. 39:663–681.
1979.
|
|
19
|
Li Y and Schellhorn HE: New developments
and novel therapeutic perspectives for vitamin C. J Nutr.
137:2171–2184. 2007.PubMed/NCBI
|
|
20
|
Jariwalla RJ and Harakeh S: Antiviral and
immunomodulatory activities of ascorbic acid. Subcell Biochem.
25:213–231. 1996.PubMed/NCBI
|
|
21
|
Harakeh S, Abu-El-Ardat K, Diab-Assaf M,
Niedzwiecki A, El-Sabban M and Rath M: Epigallocatechin-3-gallate
induces apoptosis and cell cycle arrest in HTLV-1-positive and
-negative leukemia cells. Med Oncol. 25:30–39. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Harakeh S, Diab-Assaf M, Azar R, Hassan
HM, Tayeb S, Abou-El-Ardat K, Damanhouri GA, Qadri I, Abuzenadah A,
Chaudhary A, Kumosani T, Niedzwiecki A, Rath M, Yacoub H, Azhar E
and Barbour E: Epigallocatechin-3-gallate inhibits tax-dependent
activation of nuclear factor kappa B and of matrix
metalloproteinase 9 in human T-cell lymphotropic virus-1 positive
leukemia cells. Asian Pac J Cancer Prev. 15:1219–1225. 2014.
View Article : Google Scholar
|
|
23
|
Wu KC, Yang ST, Hsia TC, Yang JS, Chiou
SM, Lu CC, Wu RS and Chung JG: Suppression of cell invasion and
migration by propofol are involved in down-regulating matrix
metalloproteinase-2 and p38 MAPK signaling in A549 human lung
adenocarcinoma epithelial cells. Anticancer Res. 32:4833–4842.
2012.PubMed/NCBI
|
|
24
|
Uozumi K: Treatment of adult T-cell
leukemia. J Clin Exp Hematop. 50:9–25. 2010. View Article : Google Scholar
|
|
25
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakachi S, Nakazato T, Ishikawa C, Kimura
R, Mann DA, Senba M, Masuzaki H and Mori N: Human T-cell leukemia
virus type 1 Tax transactivates the matrix metalloproteinase 7 gene
via JunD/AP-1 signaling. Biochim Biophys Acta. 1813:731–741. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Devy J, Ouchani F, Oudot C, Helesbeux JJ,
Vanquelef E, Salesse S, Rabenoelina F, Al-Khara S, Letinois I,
Duval O, Martiny L and Charpentier E: The anti-invasive activity of
synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is
mediated by down-regulation of plasminogen activators and MT1-MMP
expression and activity. Invest New Drugs. 29:730–741. 2011.
View Article : Google Scholar
|
|
28
|
Rath M and Pauling L: Plasmin-induced
proteolysis and the role of apoprotein(a), lysine and synthetic
analogs. Orthomol Med. 7:17–23. 1992.
|
|
29
|
Harakeh S, Jariwalla RJ and Pauling L:
Suppression of human immunodeficiency virus replication by
ascorbate in chronically and acutely infected cells. Proc Natl Acad
Sci USA. 87:7245–7249. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Harakeh S and Jariwalla RJ: Comparative
study of the anti-HIV activities of ascorbate and thiol-containing
reducing agents in chronically HIV-infected cells. Am J Clin Nutr.
54:S1231–S1235. 1991.PubMed/NCBI
|
|
31
|
Harakeh S, Niedzwiecki A and Jariwalla RJ:
Mechanistic aspects of ascorbate inhibition of human
immunodeficiency virus. Chem Biol Interact. 91:207–215. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Harakeh S and Jariwalla RJ: Ascorbate
effect on cytokine stimulation of HIV production. Nutrition.
11:684–687. 1995.PubMed/NCBI
|
|
33
|
Harakeh S and Jariwalla RJ: NF-kappa
B-independent suppression of HIV expression by ascorbic acid. AIDS
Res Hum Retroviruses. 13:235–239. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu JW, Nagao N, Kageyama K and Miwa N:
Antimetastatic and anti-invasive ability of phospho-ascorbyl
palmitate through intracellular ascorbate enrichment and the
resultant antioxidant action. Oncol Res. 11:479–487. 1999.
|
|
35
|
Nagao N, Nakayama T, Etoh T, Saiki I and
Miwa N: Tumor invasion is inhibited by phosphorylated ascorbate via
enrichment of intracellular vitamin C and decreasing of oxidative
stress. Cancer Res Clin Oncol. 126:511–518. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lovaas JD, Zhu L, Chiao CY, Byles V,
Faller DV and Dai Y: SIRT1 enhances matrix metalloproteinase-2
expression and tumor cell invasion in prostate cancer cells.
Prostate. 73:522–530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fu X, Kassim SY, Parks WC and Heinecke JW:
Hypochlorous acid generated by myeloperoxidase modifies adjacent
tryptophan and glycine residues in the catalytic domain of matrix
metalloproteinase-7 (matrilysin): an oxidative mechanism for
restraining proteolytic activity during inflammation. J Biol Chem.
278:28403–28409. 2003. View Article : Google Scholar
|
|
38
|
Du J, Martin SM, Levine M, Wagner BA,
Buettner GR, Wang SH, Taghiyev AF, Du C, Knudson CM and Cullen JJ:
Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer.
Clin Cancer Res. 16:509–520. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Frömberg A, Gutsch D, Schulze D,
Vollbracht C, Weiss G, Czubayko F and Aigner A: Ascorbate exerts
antiproliferative effects through cell cycle inhibition and
sensitizes tumor cells towards cytostatic drugs. Cancer Chemother
Pharmacol. 67:1157–1166. 2011.
|
|
40
|
Taper HS, Jamison JM, Gilloteaux J,
Summers JL and Calderon PB: Inhibition of the development of
metastases by dietary vitamin C:K3 combination. Life Sci.
75:955–967. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Maeda-Yamamoto M, Suzuki N, Sawai Y,
Miyase T, Sano M, Hashimoto-Ohta A and Isemura M: Association of
suppression of extracellular signal-regulated kinase
phosphorylation by epigallocatechin gallate with the reduction of
matrix metalloproteinase activities in human fibrosarcoma HT1080
cells. J Agric Food Chem. 51:1858–1863. 2003. View Article : Google Scholar
|
|
42
|
Lu L, Liu HM and Tang WX: Effect of
epigallocatechin-3-gallate on the invasiveness of hepatocarcinoma
cells in vitro. Zhonghua Gan Zang Bing Za Zhi. 15:825–827.
2007.PubMed/NCBI
|
|
43
|
Sen T, Moulik S, Dutta A, Choudhury PR,
Banerji A, Das S, Roy M and Chatterjee A: Multifunctional effect of
epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A
(MMP-2) in human breast cancer cell line MCF-7. Life Sci.
84:194–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen PN, Chu SC, Kuo WH, Chou MY, Lin JK
and Hsieh YS: Epigallocatechin-3 gallate inhibits invasion,
epithelial-mesenchymal transition, and tumor growth in oral cancer
cells. J Agric Food Chem. 59:836–844. 2011.PubMed/NCBI
|
|
45
|
Li H, Li Z, Xu YM, Wu Y, Yu KK, Zhang C,
Ji YH, Ding G and Chen FX: Epigallocatechin-3-gallate induces
apoptosis, inhibits proliferation and decreases invasion of glioma
cell. Neurosci Bull. 30:67–73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Demeule M, Brossard M, Pagé M, Gingras D
and Béliveau R: Matrix metalloproteinase inhibition by green tea
catechins. Biochim Biophys Acta. 1478:51–60. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Koo BH, Kim YH, Han JH and Kim DS:
Dimerization of matrix metalloproteinase-2 (MMP-2): functional
implication in MMP-2 activation. J Biol Chem. 287:22643–22653.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mannello F and Medda V: Nuclear
localization of matrix metalloproteinases. Prog Histochem Cytochem.
47:27–58. 2012. View Article : Google Scholar
|
|
49
|
Annabi B, Lachambre MP, Bousquet-Gagnon N,
Pagé M, Gingras D and Béliveau R: Green tea polyphenol
(−)-epigallocatechin 3-gallate inhibits MMP-2 secretion and
MT1-MMP-driven migration in glioblastoma cells. Biochim Biophys
Acta. 1542:209–220. 2002.
|
|
50
|
Farabegoli F, Papi A and Orlandi M:
(−)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9
and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant
cells. Biosci Rep. 31:99–108. 2011.
|
|
51
|
Peng CC, Hsieh CL, Wang HE, Chung JY, Chen
KC and Peng RY: Ferulic acid is nephrodamaging while gallic acid is
renal protective in long term treatment of chronic kidney disease.
Clin Nutr. 31:405–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Deng YT and Lin JK: EGCG inhibits the
invasion of highly invasive CL1-5 lung cancer cells through
suppressing MMP-2 expression via JNK signaling and induces G2/M
arrest. J Agric Food Chem. 59:13318–13327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vayalil PK and Katiyar SK: Treatment of
epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and
-9 via inhibition of activation of mitogen-activated protein
kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145
cells. Prostate. 59:33–42. 2004. View Article : Google Scholar
|
|
54
|
Shankar S, Marsh L and Srivastava RK: EGCG
inhibits growth of human pancreatic tumors orthotopically implanted
in Balb C nude mice through modulation of FKHRL1/FOXO3a and
neuropilin. Mol Cell Biochem. 372:83–94. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Qin J, Wang Y, Bai Y, Yang K, Mao Q, Lin
Y, Kong D, Zheng X and Xie L: Epigallocatechin-3-gallate inhibits
bladder cancer cell invasion via suppression of NF-κB-mediated
matrix metalloproteinase-9 expression. Mol Med Rep. 6:1040–1044.
2012.PubMed/NCBI
|
|
56
|
Yue H, Uzui H, Lee JD, Shimizu H and Ueda
T: Effects of magnesium on matrix metalloproteinase-2 production in
cultured rat cardiac fibroblasts. Basic Res Cardiol. 99:257–263.
2004.
|
|
57
|
Lentsch AB, Kato A, Saari JT and Schuschke
DA: Augmented metalloproteinase activity and acute lung injury in
copper-deficient rats. Am J Physiol Lung Cell Mol Physiol.
281:L387–L393. 2001.PubMed/NCBI
|
|
58
|
Romagnoli C, Marcucci T, Picariello L,
Tonelli F, Vincenzini MT and Iantomasi T: Role of N-acetylcysteine
and GSH redox system on total and active MMP-2 in intestinal
myofibroblasts of Crohn’s disease patients. Int J Colorectal Dis.
28:915–924. 2013.PubMed/NCBI
|
|
59
|
Rezaei A, Ardestani SK, Forouzandeh M,
Tavangar SM, Khorramizadeh MR, Payabvash S, Nezami BG, Jahanshiri
Z, Tavakoli Z, Shariftabrizi A and Dehpour AR: The effects of
N-acetylcysteine on the expression of matrix metalloproteinase-2
and tissue inhibitor of matrix metalloproteinase-2 in hepatic
fibrosis in bile duct ligated rats. Hepatol Res. 38:1252–1263.
2008.PubMed/NCBI
|
|
60
|
Jiang C, Ganther H and Lu J: Monomethyl
selenium - specific inhibition of MMP-2 and VEGF expression:
implications for angiogenic switch regulation. Mol Carcinog.
29:236–250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Rooprai HK, Kyriazis I, Nuttall RK,
Edwards DR, Zicha D, Aubyn D, Davies D, Gullan R and Pilkington GJ:
Inhibition of invasion and induction of apoptosis by selenium in
human malignant brain tumour cells in vitro. Int J Oncol.
30:1263–1271. 2007.PubMed/NCBI
|
